HeartBeam has announced a senior leadership change ahead of key milestones in 2023 including FDA clearance for the HeartBeam AIMI system and FDA submission of the HeartBeam AIMIGo 3D vector ECG first generation product. HeartBeam President Robert Eno will be assuming the duties and responsibilities of Executive Vice President and Chief Business Officer Jon Hunt, Ph.D., who will be stepping down from his current position and transitioning to the role of strategic advisor and consultant for the Company, effective March 15.
Published first on TheFly